 |
This article does not cite any sources. Please help improve this articlebyadding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Ortho-McNeil Pharmaceutical" – news · newspapers · books · scholar · JSTOR (January 2020) (Learn how and when to remove this message) |
 | |
| Company type | Subsidiary (ofJohnson & Johnson) |
|---|---|
| Industry |
|
| Founded | Merger of Ortho Pharmaceutical & McNeil Pharmaceutical (1993; 31 years ago (1993)) |
| Products | See list of Johnson & Johnson products |
| Website | jnj |
The Ortho-McNeil Pharmaceutical was formed from the merger of Ortho Pharmaceutical and McNeil Pharmaceutical in 1993. Both of these pharmaceutical companies are pioneers and leaders in areas such as pain management, acid reflux disease, and infectious diseases. Ortho-McNeil and Janssen Pharmaceutica together compose the Ortho-McNeil-Janssen group within Johnson & Johnson.
Ortho-McNeil is headquartered in Raritan, New Jersey, United States.
Amongst its many prescription drugs are:
|
| |||||
|---|---|---|---|---|---|
| Current |
| ||||
| Former |
| ||||
| |||||
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
